Phenotype-Tailored Lifestyle Intervention for Obesity: a Randomized Trial
Recruiting
- Conditions
- Obesity
- Registration Number
- NCT06770049
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this study is to develop an evidence-based precision medicine approach for obesity that enhances weight loss and promotes weight loss maintenance.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 228
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total Body Weight Loss (TBWL) Baseline, 52 weeks Change in Total Body Weight Loss (TBWL) in kg
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What metabolic biomarkers identify responders to phenotype-tailored obesity interventions in NCT06770049?
How does precision lifestyle therapy in NCT06770049 compare to standard behavioral weight loss programs?
What molecular pathways link obesity phenotypes to sustained weight loss in Mayo Clinic's observational trial?
Are there genetic predictors of long-term weight maintenance in NCT06770049's precision medicine approach?
What adverse events are associated with phenotype-specific dietary/lifestyle interventions in obesity trials?
Trial Locations
- Locations (1)
Mayo Clinic
🇺🇸Rochester, Minnesota, United States